THERAPEUTIC DRUG MONITORING OF INFLIXIMAB IN INFLAMMATORY RHEUMATIC DISEASES: REAL-LIFE DATA IN A COHORT OF PATIENTS

被引：0
|
作者：
Martin Lopez, M. [1 ]
Molina Esteban, N. [1 ]
Cabrera, O. [2 ]
Pablos, J. L. [1 ]
机构：
[1] Hosp Univ 12 Octubre, Inst Invest i12, Rheumatol, Madrid, Spain
[2] Hosp Univ 12 Octubre, Immunol, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Spondyloarthritis; bDMARD; Rheumatoid arthritis;
D O I：
10.1136/annrheumdis-2023-eular.4892
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0964
引用
收藏
页码：1700 / 1701
页数：2
相关论文
共 50 条
  • [21] Role of Thiopurines in Pediatric Inflammatory Bowel Diseases: A Real-Life Prospective Cohort Study
    Atia, Ohad
    Ledder, Oren
    Ben-Moshe, Tehila
    Lev-Tzion, Raffi
    Rachmen, Yelana
    Meyer, Esther O.
    Beeri, Rachel
    Renbaum, Pinhas
    Shamasneh, Ibrahim
    Shteyer, Eyal
    Turner, Dan
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 70 (06): : 825 - 832
  • [22] Serum trough infliximab and anti-infliximab antibodies in a cohort of gastroenterology and rheumatology patients' infliximab therapeutic drug monitoring
    Barlow, Nicola L.
    Mohammed, Pervaz
    Berg, Jonathan D.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2016, 53 (04) : 477 - 484
  • [23] Therapeutic drug monitoring of infliximab in inflammatory bowel disease patients in a teaching hospital setting: results of a prospective cohort study
    Warman, Andrea
    Straathof, Jan Willem A.
    Derijks, Luc J. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (03) : 242 - 248
  • [24] Use of infliximab and associated costs in inflammatory bowel disease patients: an analysis of real-life health claims data in the Netherlands
    Hoekman, D.
    Bots, S.
    Benninga, M.
    Smeets, H.
    D'Haens, G.
    Lowenberg, M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S456 - S456
  • [25] Use of Infliximab and Associated Costs in Inflammatory Bowel Disease Patients: An Analysis of Real-Life Health Claims Data in the Netherlands
    Hoekman, Daniel R.
    Bots, Steven
    Benninga, Marc A.
    Smeets, Hugo M.
    D'Haens, Geert R.
    Lowenberg, Mark
    GASTROENTEROLOGY, 2016, 150 (04) : S787 - S787
  • [26] Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (02) : 369 - 370
  • [27] Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions
    Krasselt, Marco
    Wagner, Ulf
    Nguyen, Phuong
    Pietsch, Corinna
    Boldt, Andreas
    Baerwald, Christoph
    Pierer, Matthias
    Seifert, Olga
    RHEUMATOLOGY, 2022, 61 (SI2) : SI180 - SI188
  • [28] Concomitant Medication Frequency and Profiles in a Real-Life Canadian Cohort of RA Patients Treated with Infliximab
    Khraishi, Majed
    Choquette, Denis
    Sampalis, John
    Rampakakis, Emmanouil
    Kahlil, Hayssam
    Otawa, Susan
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1752 - 1752
  • [29] ETANAR - A ETANERCEPT BIOSIMILAR IS AS EFFECTIVE AS ADALIMUMAB AND INFLIXIMAB IN A COHORT OF REAL-LIFE OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Santos-Moreno, P.
    Saavedra-Martinez, G.
    Villarreal, L.
    Gomez, D.
    Bello-Gualtero, J.
    Giraldo, V.
    Martinez, P.
    Sanchez, A.
    Sanchez, M.
    Uribe, E.
    Boon, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 789 - 790
  • [30] Correlation of CDAI and SDAI with DAS in a Large, Real-life Cohort of RA Patients Treated With Infliximab
    Choquette, Denis
    Bensen, Bill
    Baker, Milton
    Khalil, Hayssam
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1155 - 1155
12345